Mirati Therapeutics (MRTX) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

Mirati Therapeutics (MRTX) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 6, 2023 (07:10)

Sector: Healthcare

The share price of Mirati Therapeutics, Inc. (MRTX) now

Latest session on the 5th of December for
Mirati Therapeutics, Inc. is negative
Trading Volume: 818088
Open: 56.84 /  High: 56.92 /  Low: 56.65
What analysts predict: $60.69
52-week High/Low: $80.3 / $27.3

50/200 Day Moving Average: $53.93 / $42.75

This figure corresponds to the Average Price over the previous 50/200 days. For Mirati Therapeutics stocks, the 50-day moving average is the support level today.

For Mirati Therapeutics stocks, the 200-day moving average is the support level today.

Are you interested in Mirati Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Mirati Therapeutics stock price in 2024, 2025, 2026, 2027, 2028. How much will one Mirati Therapeutics share be worth in 2024 - 2028?

When should I take profit in Mirati Therapeutics stock? When should I record a loss on Mirati Therapeutics stock? What are analysts' forecasts for Mirati Therapeutics stock? What is the future of Mirati Therapeutics stock? We forecast Mirati Therapeutics stock performance using neural networks based on historical data on Mirati Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Mirati Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Mirati Therapeutics shares. This happens once a day.




Historical and forecast chart of Mirati Therapeutics stock

The chart below shows the historical price of Mirati Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Mirati Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Mirati Therapeutics, Inc. is a clinical stage biopharmaceutical company. The company is focused on developing a pipeline of targeted cancer drugs. The company is developing candidate products to combat genetic and immunological cancer promoters. Its clinical programs consist of two candidate products: MRTX849, a Kirsten rat sarcoma inhibitor (KRAS) G12C, and Sitravatinib, a multi-kinase inhibitor. His KRAS inhibitor program is focused on the discovery and development of small molecule compounds that target KRAS G12C and G12D. MRTX849 is designed to inhibit the KRAS G12C mutations that are present in patients with non-small cell lung cancer (NSCLC), adenocarcinoma, colorectal cancer (CRC), pancreatic cancer, and several other intractable cancers. Sitravatinib is a spectrally selective kinase inhibitor designed to inhibit receptor tyrosine kinases (RTKs) including TAM family receptors (TYRO3, Axl, Mer), split family receptors (VEGFR2, KIT) and RET.

Mirati Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Dec 08 56.94 55.78 58.27 4.47
Dec 09 57.36 56.47 58.48 3.55
Dec 10 57.80 56.26 58.57 4.10
Dec 11 57.25 55.99 57.69 3.04
Dec 12 58.43 57.80 59.74 3.36
Dec 13 60.32 59.49 61.25 2.95
Dec 14 59.70 59.20 60.50 2.19
Dec 15 59.16 57.90 59.60 2.93
Dec 16 58.64 57.60 59.26 2.89
Dec 17 58.42 57.68 59.42 3.01
Dec 18 58.66 58.03 59.26 2.12
Dec 19 57.92 56.95 59.30 4.13
Dec 20 57.11 56.63 58.09 2.58
Dec 21 56.47 54.89 57.44 4.64
Dec 22 57.54 56.45 58.10 2.93
Dec 23 57.90 56.79 58.33 2.71
Dec 24 56.91 56.27 57.69 2.51
Dec 25 57.69 56.74 59.24 4.41
Dec 26 55.69 54.28 56.70 4.45
Dec 27 55.45 54.17 56.97 5.16
Dec 28 56.35 55.42 56.88 2.63
Dec 29 56.90 55.96 57.56 2.85
Dec 30 57.00 56.00 57.94 3.46
Dec 31 56.38 55.06 57.52 4.48
Jan 01 57.94 56.74 59.46 4.79
Jan 02 58.55 57.22 59.55 4.08
Jan 03 57.03 56.59 58.33 3.07
Jan 04 57.71 57.18 58.38 2.08
Jan 05 56.66 56.00 57.71 3.05
Jan 06 56.62 55.69 57.21 2.74

Mirati Therapeutics Daily Price Targets


Mirati Therapeutics Stock Forecast 12-08-2023.

Forecast target price for 12-08-2023: $56.94.
Positive dynamics for Mirati Therapeutics shares will prevail with possible volatility of 4.275%.
Pessimistic target level: 55.78
Optimistic target level: 58.27

Mirati Therapeutics Stock Forecast 12-09-2023.

Forecast target price for 12-09-2023: $57.36.
Positive dynamics for Mirati Therapeutics shares will prevail with possible volatility of 3.433%.
Pessimistic target level: 56.47
Optimistic target level: 58.48

Mirati Therapeutics Stock Forecast 12-10-2023.

Forecast target price for 12-10-2023: $57.80.
Positive dynamics for Mirati Therapeutics shares will prevail with possible volatility of 3.938%.
Pessimistic target level: 56.26
Optimistic target level: 58.57

Mirati Therapeutics Stock Forecast 12-11-2023.

Forecast target price for 12-11-2023: $57.25.
Negative dynamics for Mirati Therapeutics shares will prevail with possible volatility of 2.952%.
Pessimistic target level: 55.99
Optimistic target level: 57.69

Mirati Therapeutics Stock Forecast 12-12-2023.

Forecast target price for 12-12-2023: $58.43.
Positive dynamics for Mirati Therapeutics shares will prevail with possible volatility of 3.252%.
Pessimistic target level: 57.80
Optimistic target level: 59.74

Mirati Therapeutics Stock Forecast 12-13-2023.

Forecast target price for 12-13-2023: $60.32.
Positive dynamics for Mirati Therapeutics shares will prevail with possible volatility of 2.861%.
Pessimistic target level: 59.49
Optimistic target level: 61.25

MRTX (MRTX) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan. 63.52 59.04 65.99 10.54
Feb. 71.04 66.57 73.49 9.42
Mar. 72.11 68.00 78.92 13.84
Apr. 67.35 62.00 72.60 14.61
May. 61.19 58.16 66.14 12.07
Jun. 59.63 53.19 62.76 15.25
Jul. 55.96 51.18 61.42 16.67
Aug. 58.81 55.20 64.81 14.84
Sep. 58.28 54.44 63.88 14.78
Oct. 51.29 49.52 55.91 11.42
Nov. 49.83 45.34 54.99 17.54
Dec. 50.28 48.17 55.03 12.47

Mirati Therapeutics forecast for this year


Mirati Therapeutics Stock Prediction for Jan 2024

An uptrend is forecast for this month with an optimal target price of $63.5166. Pessimistic: $59.04. Optimistic: $65.99


Mirati Therapeutics Stock Prediction for Feb 2024

An uptrend is forecast for this month with an optimal target price of $71.0433. Pessimistic: $66.57. Optimistic: $73.49


Mirati Therapeutics Stock Prediction for Mar 2024

An uptrend is forecast for this month with an optimal target price of $72.1089. Pessimistic: $68.00. Optimistic: $78.92


Mirati Therapeutics Stock Prediction for Apr 2024

An downtrend is forecast for this month with an optimal target price of $67.3497. Pessimistic: $62.00. Optimistic: $72.60


Mirati Therapeutics Stock Prediction for May 2024

An downtrend is forecast for this month with an optimal target price of $61.1872. Pessimistic: $58.16. Optimistic: $66.14


Mirati Therapeutics Stock Prediction for Jun 2024

An downtrend is forecast for this month with an optimal target price of $59.627. Pessimistic: $53.19. Optimistic: $62.76


Mirati Therapeutics Stock Prediction for Jul 2024

An downtrend is forecast for this month with an optimal target price of $55.9599. Pessimistic: $51.18. Optimistic: $61.42


Mirati Therapeutics Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $58.8139. Pessimistic: $55.20. Optimistic: $64.81


Mirati Therapeutics Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $58.2845. Pessimistic: $54.44. Optimistic: $63.88


Mirati Therapeutics Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $51.2904. Pessimistic: $49.52. Optimistic: $55.91


Mirati Therapeutics Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $49.8286. Pessimistic: $45.34. Optimistic: $54.99


Mirati Therapeutics Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $50.2771. Pessimistic: $48.17. Optimistic: $55.03



Mirati Therapeutics (MRTX) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 56.76 50.38 62.47 19.35
Feb 62.13 58.87 68.09 13.55
Mar 70.79 67.71 78.97 14.25
Apr 67.61 61.93 74.10 16.42
May 66.29 61.62 70.86 13.05
Jun 64.80 57.22 69.85 18.09
Jul 72.28 67.62 76.08 11.12
Aug 77.59 73.29 80.50 8.96
Sep 73.75 67.45 82.49 18.24
Oct 77.52 73.10 83.33 12.28
Nov 68.56 63.93 76.48 16.41
Dec 70.00 66.75 74.31 10.17

Mirati Therapeutics (MRTX) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 73.68 68.59 78.10 12.17
Feb 74.23 68.55 76.57 10.47
Mar 76.68 72.54 79.33 8.55
Apr 65.75 61.71 69.40 11.08
May 63.58 61.20 70.93 13.72
Jun 62.06 57.50 69.50 17.28
Jul 54.52 52.39 58.12 9.85
Aug 61.14 56.28 66.28 15.08
Sep 62.52 58.95 64.95 9.24
Oct 66.08 61.82 73.71 16.14
Nov 62.71 59.32 66.57 10.88
Dec 62.33 59.44 69.35 14.29

Mirati Therapeutics (MRTX) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 65.33 61.50 69.44 11.43
Feb 73.75 68.00 81.83 16.90
Mar 82.38 72.50 90.41 19.82
Apr 77.19 73.02 79.97 8.69
May 69.55 64.65 77.06 16.11
Jun 71.32 67.47 74.64 9.60
Jul 70.25 63.40 77.42 18.10
Aug 68.88 64.54 72.81 11.35
Sep 76.74 73.51 82.26 10.63
Oct 71.56 67.80 80.14 15.40
Nov 71.23 65.89 74.33 11.36
Dec 79.25 75.44 82.46 8.51

Mirati Therapeutics (MRTX) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 90.07 83.31 96.42 13.59
Feb 91.01 80.23 99.48 19.35
Mar 87.05 84.44 96.98 12.93
Apr 90.45 87.19 96.82 9.95
May 85.56 77.48 93.78 17.38
Jun 76.32 67.28 81.47 17.42
Jul 68.77 60.51 71.55 15.43
Aug 73.82 70.50 81.90 13.93
Sep 70.72 68.17 78.89 13.58
Oct 67.33 65.31 75.30 13.28
Nov 74.80 67.84 80.41 15.63
Dec 69.75 65.46 76.13 14.02

Mirati Therapeutics information and performance

Mirati Therapeutics Address

9393 TOWNE CENTRE DRIVE, SUITE 200, SAN DIEGO, CA, US

Market Capitalization: 4 004 031 000 $

Market capitalization of the Mirati Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of MRTX shares in the company outstanding by the market price of one share.

EBITDA: -760 681 984 $

EBITDA of Mirati Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -12.18

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 2.02
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 113.06

Enterprise Value (EV) /Revenue

EV To EBITDA: -3.969

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 70148000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.